Home/Pipeline/Axon Therapy® mPNS

Axon Therapy® mPNS

Chronic Intractable Pain, Post-Surgical Pain, Post-Traumatic Pain, Painful Diabetic Neuropathy (Lower Extremities)

ApprovedActive

Key Facts

Indication
Chronic Intractable Pain, Post-Surgical Pain, Post-Traumatic Pain, Painful Diabetic Neuropathy (Lower Extremities)
Phase
Approved
Status
Active
Company

About Neuralace Medical

Neuralace Medical is a commercial-stage private company that has achieved FDA clearance for its flagship Axon Therapy® mPNS system, a first-of-its-kind, completely non-invasive neuromodulation device for chronic neuropathic pain. The technology uses high-intensity magnetic fields to target peripheral nerves without implants or injections, positioning it as a potential alternative to opioids and invasive surgical interventions. With published clinical data showing significant pain reduction, the company is targeting the vast chronic pain market with a therapy designed for ease of use in clinical settings. Leadership includes seasoned medtech executives focused on commercial growth and expanding the platform's indications.

View full company profile